Eastern Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80.2M | Sell |
318,655
-56,180
| -15% | -$12.1M | 1.23% | 23 |
|
|
2026
Q1 | $81.5M | Sell |
374,835
-5,634
| -1% | -$1.25M | 1.4% | 19 |
|
|
2025
Q4 | $86.9M | Buy |
380,469
+2,481
| +0.7% | +$565K | 1.5% | 18 |
|
|
2025
Q3 | $87.5M | Buy |
377,988
+1,478
| +0.4% | +$301K | 1.55% | 19 |
|
|
2025
Q2 | $69.9M | Buy |
376,510
+4,316
| +1% | +$802K | 1.33% | 20 |
|
|
2025
Q1 | $78M | Buy |
372,194
+82,030
| +28% | +$15.9M | 1.53% | 19 |
|
|
2024
Q4 | $51.6M | Buy |
290,164
+77,889
| +37% | +$14.3M | 0.96% | 25 |
|
|
2024
Q3 | $41.9M | Buy |
212,275
+78,551
| +59% | +$14.7M | 0.75% | 40 |
|
|
2024
Q2 | $22.9M | Buy |
133,724
+3,428
| +3% | +$568K | 0.93% | 38 |
|
|
2024
Q1 | $23.7M | Buy |
130,296
+8,743
| +7% | +$1.51M | 0.99% | 37 |
|
|
2023
Q4 | $18.8M | Sell |
121,553
-3,883
| -3% | -$566K | 0.86% | 43 |
|
|
2023
Q3 | $18.7M | Buy |
125,436
+266
| +0.2% | +$39K | 0.93% | 39 |
|
|
2023
Q2 | $16.9M | Buy |
125,170
+19,905
| +19% | +$2.92M | 0.8% | 52 |
|
|
2023
Q1 | $16.8M | Buy |
105,265
+7,758
| +8% | +$1.19M | 0.84% | 51 |
|
|
2022
Q4 | $15.8M | Buy |
97,507
+450
| +0.5% | +$69K | 0.84% | 49 |
|
|
2022
Q3 | $13M | Buy |
97,057
+1,218
| +1% | +$175K | 0.74% | 52 |
|
|
2022
Q2 | $14.7M | Buy |
95,839
+72,654
| +313% | +$11.1M | 0.78% | 53 |
|
|
2022
Q1 | $3.76M | Buy |
23,185
+14,713
| +174% | +$2.14M | 0.17% | 91 |
|
|
2021
Q4 | $1.15M | Buy |
8,472
+109
| +1% | +$12.9K | 0.05% | 129 |
|
|
2021
Q3 | $902K | Hold |
8,363
| – | – | 0.04% | 129 |
|
|
2021
Q2 | $942K | Sell |
8,363
-93
| -1% | -$10.5K | 0.05% | 131 |
|
|
2021
Q1 | $915K | Sell |
8,456
-539
| -6% | -$57.7K | 0.05% | 131 |
|
|
2020
Q4 | $964K | Sell |
8,995
-29
| -0.3% | -$2.79K | 0.05% | 120 |
|
|
2020
Q3 | $791K | Sell |
9,024
-139
| -2% | -$13.1K | 0.05% | 120 |
|
|
2020
Q2 | $900K | Sell |
9,163
-204
| -2% | -$18K | 0.06% | 115 |
|
|
2020
Q1 | $714K | Sell |
9,367
-561
| -6% | -$47.8K | 0.05% | 119 |
|
|
2019
Q4 | $879K | Sell |
9,928
-1,923
| -16% | -$160K | 0.05% | 112 |
|
|
2019
Q3 | $898K | Sell |
11,851
-2,653
| -18% | -$182K | 0.06% | 110 |
|
|
2019
Q2 | $1.05M | Sell |
14,504
-14,103
| -49% | -$1.11M | 0.07% | 108 |
|
|
2019
Q1 | $2.31M | Sell |
28,607
-128,280
| -82% | -$10.5M | 0.15% | 94 |
|
|
2018
Q4 | $14.5M | Sell |
156,887
-1,892
| -1% | -$166K | 1.08% | 37 |
|
|
2018
Q3 | $15M | Buy |
158,779
+1,210
| +0.8% | +$115K | 0.98% | 47 |
|
|
2018
Q2 | $14.6M | Buy |
157,569
+4,980
| +3% | +$486K | 1% | 43 |
|
|
2018
Q1 | $14.4M | Buy |
152,589
+99,675
| +188% | +$10.9M | 1.01% | 40 |
|
|
2017
Q4 | $5.12M | Sell |
52,914
-10,064
| -16% | -$948K | 0.34% | 79 |
|
|
2017
Q3 | $5.6M | Sell |
62,978
-441
| -0.7% | -$33.6K | 0.4% | 78 |
|
|
2017
Q2 | $4.6M | Buy |
63,419
+2,112
| +3% | +$142K | 0.34% | 80 |
|
|
2017
Q1 | $4M | Sell |
61,307
-1,158
| -2% | -$72.8K | 0.3% | 83 |
|
|
2016
Q4 | $3.91M | Buy |
62,465
+342
| +0.6% | +$20.9K | 0.3% | 79 |
|
|
2016
Q3 | $3.92M | Sell |
62,123
-16,592
| -21% | -$1.07M | 0.31% | 79 |
|
|
2016
Q2 | $4.87M | Buy |
78,715
+2,179
| +3% | +$133K | 0.39% | 78 |
|
|
2016
Q1 | $4.37M | Buy |
76,536
+699
| +0.9% | +$39K | 0.36% | 77 |
|
|
2015
Q4 | $4.49M | Sell |
75,837
-376
| -0.5% | -$21.7K | 0.37% | 73 |
|
|
2015
Q3 | $4.15M | Buy |
76,213
+532
| +0.7% | +$34.6K | 0.36% | 73 |
|
|
2015
Q2 | $5.08M | Sell |
75,681
-450
| -0.6% | -$29.4K | 0.41% | 71 |
|
|
2015
Q1 | $4.46M | Buy |
76,131
+9,175
| +14% | +$554K | 0.36% | 74 |
|
|
2014
Q4 | $4.38M | Buy |
66,956
+175
| +0.3% | +$11K | 0.35% | 71 |
|
|
2014
Q3 | $3.86M | Buy |
66,781
+11,636
| +21% | +$646K | 0.31% | 72 |
|
|
2014
Q2 | $3.11M | Buy |
55,145
+974
| +2% | +$51.1K | 0.25% | 74 |
|
|
2014
Q1 | $2.78M | Buy |
54,171
+35,020
| +183% | +$1.77M | 0.23% | 73 |
|
|
2013
Q4 | $1.01M | Sell |
19,151
-2,082
| -10% | -$102K | 0.09% | 105 |
|
|
2013
Q3 | $950K | Sell |
21,233
-1,427
| -6% | -$63.3K | 0.09% | 110 |
|
|
2013
Q2 | $937K | Buy |
+22,660
| New | +$991K | 0.09% | 107 |
|
Other funds holding ABBV
ECSS
ATO
Eastern Bank's ABBV Position: Q2 2026 in Review
Eastern Bank reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $12.1M and leaving 318,655 shares worth $80.2M. The position accounts for 1.23% of the portfolio, ranked #23.
Eastern Bank first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $87.5M in Q3 2025. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Eastern Bank held 318,655 shares of AbbVie worth $80.2M as of Q2 2026.
- Eastern Bank sold 56,180 AbbVie shares in Q2 2026, an estimated $12.1M.
- AbbVie made up 1.23% of Eastern Bank's portfolio in Q2 2026, its #23 holding.
- Eastern Bank first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Eastern Bank's AbbVie position peaked at $87.5M in Q3 2025.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.